Removal of Bilirubin by Albumin Binding during Intermittent Peritoneal Dialysis Authors : Arthur P. Grollman , M.D. , and Gerard B. Odell , M.D. Author Info & Affiliations Published August 9, 1962 ...

In addition to characterizing the PK of albumin formatted therapeutics, Tg32 hAlb mice can also be used to characterize therapeutics engineered to bind to and be carried by human albumin.

EPO grants Sonnet EU Patent No. EP3583125 B1 for Fully Human Albumin Binding (FHAB®) domain fusion proteins, expanding global IP protection. Quiver AI Summary ...

A paper appeared in International Journal of Pharmaceutics. A team of researchers from Kazan Federal University, Russia, led by Dr. Igor Sedov, reported an application of capillary differential ...

Albumin is the main transport protein in blood plasma and can bind to a wide variety of molecules. Albumin has a two-domain structure with at least two high-affinity and several low-affinity ...

The team leveraged nanobodies—small antibody-like molecules that are derived from llamas and other cameloid species—that bind to serum albumin, the most abundant protein in the blood.

Albumin boosted zinc and C-peptide binding to MS red blood cells, and this effect went away with interferon beta treatment. From these data, ...

Klammt, S, Wojak, HJ, Mitzner, A, et al. Albumin-binding capacity (ABiC) is reduced in patients with chronic kidney disease along with an accumulation of protein-bound uraemic toxins.